tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OLMA Stock Latest News

Olema Pharmaceuticals CFO Departs; CEO Assumes Interim Role
Company AnnouncementsOlema Pharmaceuticals CFO Departs; CEO Assumes Interim Role
6d ago
8K
OLMA
Olema Oncology announces departure of COO, CFO Shane Kovacs
PremiumThe Fly
Olema Oncology announces departure of COO, CFO Shane Kovacs
6d ago
OLMA
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
PremiumWeekend Updates
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
12d ago
APLS
IMVT
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
PremiumStock Analysis & Ideas
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
16d ago
OLMA
ORIC
Olema Highlights Palazestrant Strategy in New Investor Presentation
PremiumCompany Announcements
Olema Highlights Palazestrant Strategy in New Investor Presentation
24d ago
8K
OLMA
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
PremiumMarket News3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
29d ago
OLMA
ORIC
Olema Oncology initiated with a Buy at UBS
Premium
The Fly
Olema Oncology initiated with a Buy at UBS
29d ago
OLMA
Olema Oncology initiated with a Buy at UBS
Premium
The Fly
Olema Oncology initiated with a Buy at UBS
29d ago
OLMA
Olema Oncology initiated with an Overweight at Piper Sandler
PremiumThe Fly
Olema Oncology initiated with an Overweight at Piper Sandler
29d ago
OLMA
Citi adds ‘upside 90-day catalyst watch’ on Olema Oncology
PremiumThe Fly
Citi adds ‘upside 90-day catalyst watch’ on Olema Oncology
1M ago
OLMA
Olema Oncology rises 6.2%
PremiumThe Fly
Olema Oncology rises 6.2%
2M ago
OLMA
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
S
BRR
Citi more than doubles Olema target, opens ‘upside catalyst watch’
PremiumThe FlyCiti more than doubles Olema target, opens ‘upside catalyst watch’
2M ago
OLMA
Olema Oncology files automatic mixed securities shelf
Premium
The Fly
Olema Oncology files automatic mixed securities shelf
2M ago
OLMA
Olema Oncology price target raised to $48 from $45 at Oppenheimer
Premium
The Fly
Olema Oncology price target raised to $48 from $45 at Oppenheimer
2M ago
CHRO
OLMA
Olema Oncology price target raised to $38 from $26 at Goldman Sachs
PremiumThe Fly
Olema Oncology price target raised to $38 from $26 at Goldman Sachs
2M ago
OLMA
Promising Potential of Olema Pharmaceuticals’ Palazestrant in Transforming ER+/HER2- Breast Cancer Treatment
PremiumRatings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in Transforming ER+/HER2- Breast Cancer Treatment
2M ago
OLMA
Positive Outlook for Olema’s OPERA-02 Trial Based on Roche’s Promising Giredestrant Data
PremiumRatings
Positive Outlook for Olema’s OPERA-02 Trial Based on Roche’s Promising Giredestrant Data
2M ago
OLMA
Buy Rating for Olema Pharmaceuticals Driven by Promising Oral SERD Potential in Breast Cancer Treatment
PremiumRatings
Buy Rating for Olema Pharmaceuticals Driven by Promising Oral SERD Potential in Breast Cancer Treatment
2M ago
OLMA
Olema Oncology price target raised to $43 from $30 at Jefferies
PremiumThe FlyOlema Oncology price target raised to $43 from $30 at Jefferies
2M ago
CHRO
OLMA
Olema Oncology rises 11.7%
Premium
The Fly
Olema Oncology rises 11.7%
2M ago
OLMA
Olema Oncology price target raised to $26 from $18 at Goldman Sachs
Premium
The Fly
Olema Oncology price target raised to $26 from $18 at Goldman Sachs
3M ago
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >